RankingsPricing
  1. US-listed companies
  2. Merck & Co., Inc.
  3. Financials
  4. Diluted EPS

Merck & Co., Inc.MRK

Market cap
$251.9B
P/E ratio
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Dec 31, 20246.7+4714.29%
Dec 31, 20230.1-97.55%
Dec 31, 20225.7+11.09%
Dec 31, 20215.1+84.89%
Dec 31, 20202.8-27.03%
Dec 31, 20193.8+64.22%
Dec 31, 20182.3+166.67%
Dec 31, 20170.9-38.30%
Dec 31, 20161.4-9.62%
Dec 31, 20151.6-61.67%
Dec 31, 20144.1+176.87%
Dec 31, 20131.5-26.50%
Dec 31, 20122-0.99%
Dec 31, 20112+621.43%
Dec 31, 20100.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)